Esopump Special Precautions

In the presence of any alarm symptom (e.g. significant unintentional weight loss, recurrent vomiting, dysphagia, haematemesis or melaena) and when gastric ulcer is suspected or present, malignancy should be excluded, as treatment with Esomeprazole may alleviate symptoms and delay diagnosis.
Concomitant use of Esomeprazole and Clopidogrel should be avoided.
Some published observational studies suggest that proton pump inhibitor (PPI) therapy may be associated with a small increased risk for osteoporosis related fractures. However, in other similar observational studies no such increased risk was found.
Although a causal relationship between Omeprazole/Esomeprazole and osteoporotic fractures has not been established, patients at risk for developing osteoporosis or osteoporotic fractures are advised to have appropriate clinical monitoring in accordance with current clinical guidelines for these conditions.
Effect on ability to drive and use machines: Esomeprazole is not likely to affect the ability to drive or use machine.
Use in Pregnancy & Lactation: For Esomepazole limited data on exposed pregnancies are available. Caution should be exercised when prescribing Esomeprazole to pregnant women.
It is not known whether Esomeprazole is excreted in human breast milk. No studies in lactating women have been performed.
Therefore Esomeprazole should not be used during breast-feeding.